We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Arrowhead Pharmaceuticals Inc | NASDAQ:ARWR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 1.14% | 22.12 | 21.53 | 25.03 | 22.36 | 21.72 | 22.12 | 617,126 | 05:00:05 |
1. Name and Address of Reporting Person * GIVEN BRUCE D | 2. Issuer Name and Ticker or Trading Symbol ARROWHEAD PHARMACEUTICALS, INC. [ ARWR ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Operating Officer |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 4/20/2020 | M | 3800 | A | $4.75 | 862793 | D | |||
Common Stock | 4/20/2020 | M | 3700 | A | $5.19 | 866493 | D | |||
Common Stock | 4/20/2020 | M | 3456 | A | $5.20 | 869949 | D | |||
Common Stock | 4/20/2020 | M | 5300 | A | $14.54 | 875249 | D | |||
Common Stock | 4/20/2020 | S(1) | 3800 | D | $40.00 (2) | 871449 | D | |||
Common Stock | 4/20/2020 | S(1) | 3700 | D | $40.00 (3) | 867749 | D | |||
Common Stock | 4/20/2020 | S(1) | 3456 | D | $40.00 (2) | 864293 | D | |||
Common Stock | 4/20/2020 | S(1) | 5300 | D | $40.00 (3) | 858993 | D | |||
Common Stock | 4/20/2020 | S(1) | 3454 | D | $40.00 (2) | 855539 | D | |||
Common Stock | 4/20/2020 | S(1) | 3805 | D | $40.00 (2) | 851734 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (right to buy) | $4.75 | 4/20/2020 | M | 3800 | 10/1/2013 (4) | 9/21/2023 | Common Stock | 3800 | $0.00 | 346200 | D | ||||
Stock Option (right to buy) | $5.19 | 4/20/2020 | M | 3700 | 3/1/2012 (4) | 2/16/2022 | Common Stock | 3700 | $0.00 | 342500 | D | ||||
Stock Option (right to buy) | $5.20 | 4/20/2020 | M | 3456 | 4/1/2012 (4) | 10/26/2021 | Common Stock | 3456 | $0.00 | 339044 | D | ||||
Stock Option (right to buy) | $14.54 | 4/20/2020 | M | 5300 | 3/1/2014 (4) | 2/6/2024 | Common Stock | 5300 | $0.00 | 333744 | D |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
GIVEN BRUCE D 177 E. COLORADO BLVD SUITE 700 PASADENA, CA 91105 | Chief Operating Officer |
Signatures | ||
/S/ Bruce Given | 4/22/2020 | |
**Signature of Reporting Person | Date |
1 Year Arrowhead Pharmaceuticals Chart |
1 Month Arrowhead Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions